Membrane lipid pathology in AD

Membrane lipid pathology in AD enters the Adult Cognitive Disease corpus through the work of Cristina Quigley (submission 27), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Cristina Quigley's submission is summarised in this corpus as:

Single-molecule lipids are driving the pathophysiology of Alzheimer's disease through effects on membrane structural flexibility, inflammation, debris clearance, and protein unfolding. Liver health and lipid biosynthesis in the liver are central to AD progression through the liver-brain axis. Plasma ceramides and phosphatidylcholines are associated with AD diagnosis and hippocampal brain volume loss.

Where it sits

The submission scores against the framework's convergence nodes as: neuroimmune interface 5 · ApoE4 hub 5 · endosomal nexus 2 · compensatory paradigm 2.

Its declared subject matter: lipidomics, ceramides, phosphatidylcholines, liver-brain axis, biomarkers, hippocampal atrophy, APOE.

Named by the same submission

3 other concepts enter the corpus through the same paper, so they cover adjacent ground: Blood-based biomarker discovery · Lipid-driven neurodegeneration · Liver-brain metabolic axis.


Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier. It has not yet been expanded into an article.

Source: kb/wiki/concepts/Membrane lipid pathology in AD.md